AOS vs MRNA · P/E 19, rev $1.00B vs rev $145.0M
Smith AO Corporation (AOS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the AOS and MRNA stock pages for the full models.
Not investment advice.